A leading Alzheimer’s researcher, Dr. Aisen answers some questions about the resurrection of aducanumab as a potential therapy for Alzheimer’s...
An internist describes the benefits and risks of using cannabidiol to treat various conditions.
Updates to ACIP adult vaccination schedule include language on shared clinical decision making.
The company’s hopes lie with a secondary analysis of high-dose patients from two failed trials.
COPENHAGEN – Intriguing findings from a Danish national registry study.
AUSTIN, TEX. – Researchers also found 81 variants of unknown significance in patients, and suggested some could be...
AUSTIN, TEX. – The majority of paresthesia and cognition-related adverse events were mild or moderate with few participants discontinuing the...
AUSTIN – An interim analysis examines the use of physical therapy, surgery, medications, orthoses, and walking aids in more than 400 adults with...
AUSTIN – Particular clinical presentations and cognitive biases are associated with misdiagnosis of patients who...
AUSTIN, TEX. – Neurologists are circumspect about recommending influenza vaccination for patients with a history of...
More research is needed to understand the optimal recovery time from a neurobiological perspective, a study suggests.